Tanaka K - Search Results

1

Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma.

Konishi N, Miki C, Yoshida T, Tanaka K, Toiyama Y, Kusunoki M. Konishi N, et al. Among authors: tanaka k. Oncology. 2005;68(2-3):138-45. doi: 10.1159/000086768. Epub 2005 Jul 4. Oncology. 2005. PMID: 16006751

2

Serum immunosuppressive acidic protein as an interleukin-6 related index of deteriorating condition in gastric cancer patients.

Ikuta S, Miki C, Tanaka K, Konishi N, Mohri Y, Tonouchi H, Kusunoki M. Ikuta S, et al. Among authors: tanaka k. Dig Surg. 2003;20(6):532-8. doi: 10.1159/000073700. Epub 2003 Sep 24. Dig Surg. 2003. PMID: 14534376

3

Gene expression profiles of colorectal carcinoma in response to neo-adjuvant chemotherapy.

Inoue Y, Shirane M, Miki C, Hiro J, Tanaka K, Kobayashi M, Mori K, Yanagi H, Kusunoki M. Inoue Y, et al. Among authors: tanaka k. Int J Oncol. 2004 Dec;25(6):1641-9. Int J Oncol. 2004. PMID: 15547701 Clinical Trial.

4

Administration sequence-dependent antitumor effects of paclitaxel and 5-fluorouracil in the human gastric cancer cell line MKN45.

Toiyama Y, Tanaka K, Konishi N, Mohri Y, Tonouchi H, Miki C, Kusunoki M. Toiyama Y, et al. Among authors: tanaka k. Cancer Chemother Pharmacol. 2006 Feb;57(3):368-75. doi: 10.1007/s00280-005-0057-9. Epub 2005 Aug 2. Cancer Chemother Pharmacol. 2006. PMID: 16075279

5

in vitro synergistic antitumor activity of a combination of 5-fluorouracil and irinotecan in human colon cancer.

Inoue Y, Tanaka K, Hiro J, Yoshiyama S, Toiyama Y, Eguchi T, Miki C, Kusunoki M. Inoue Y, et al. Among authors: tanaka k. Int J Oncol. 2006 Feb;28(2):479-86. Int J Oncol. 2006. PMID: 16391804

6

Ultrasonically activated shears in gastrectomy for large gastric cancers.

Mohri Y, Tonouchi H, Tanaka K, Ohi M, Koike Y, Morimoto Y, Miki C, Kusunoki M. Mohri Y, et al. Among authors: tanaka k. Surg Today. 2007;37(12):1060-3. doi: 10.1007/s00595-007-3551-3. Epub 2007 Nov 26. Surg Today. 2007. PMID: 18030566

7

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.

Koike Y, Miki C, Okugawa Y, Yokoe T, Toiyama Y, Tanaka K, Inoue Y, Kusunoki M. Koike Y, et al. Among authors: tanaka k. J Surg Oncol. 2008 Dec 1;98(7):540-4. doi: 10.1002/jso.21154. J Surg Oncol. 2008. PMID: 18937231

8

Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.

Tanaka K, Mohri Y, Nishioka J, Kobayashi M, Ohi M, Miki C, Tonouchi H, Nobori T, Kusunoki M. Tanaka K, et al. J Surg Oncol. 2009 Apr 1;99(5):307-10. doi: 10.1002/jso.21232. J Surg Oncol. 2009. PMID: 19170129

9

A comprehensive comparative study on the characteristics of colorectal cancer chemotherapy.

Inoue Y, Toiyama Y, Tanaka K, Miki C, Kusunoki M. Inoue Y, et al. Among authors: tanaka k. Jpn J Clin Oncol. 2009 Jun;39(6):367-75. doi: 10.1093/jjco/hyp031. Epub 2009 Apr 24. Jpn J Clin Oncol. 2009. PMID: 19395468

10

Clinical significance of the gene expression profile in residual tumor cells after neoadjuvant chemo-radiotherapy for esophageal cancer.

Tanaka K, Otake K, Mohri Y, Ohi M, Yokoe T, Toiyama Y, Miki C, Tonouchi H, Kusunoki M. Tanaka K, et al. Oncol Rep. 2009 Jun;21(6):1489-94. doi: 10.3892/or_00000379. Oncol Rep. 2009. PMID: 19424628

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,805 results

Search Page

Filters